ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
57,072.01
-5.82%
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs Yen
157.9475
0.14%
Brent Oil
85.05
-0.98%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Celldex Therapeutics Inc (CLDX)

  7. Celldex Therapeutics Inc (CLDX) ニュース

CLDX Celldex Therapeutics Inc

37.42
0.00 (0.00%)
プレマーケット
最終更新日： 17:24:44
15分遅延
名称 銘柄コード 市場 種別
Celldex Therapeutics Inc CLDX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 37.42 17:24:44
始値 安値 高値 終値 前日終値
37.42
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1721:01GLOBECelldex Announces Completion of Enrollment in Phase 2 Study..
2024/3/0821:00GLOBECelldex Therapeutics to Participate in the Leerink Partners..
2024/3/0600:30GLOBECelldex Therapeutics to Present at TD Cowen’s 44th Annual..
2024/3/0600:10GLOBECelldex Therapeutics Announces Closing of Public Offering of..
2024/3/0206:10EDGAR2Form 8-K - Current report
2024/3/0206:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0111:14GLOBECelldex Therapeutics Announces Pricing of Upsized $400..
2024/2/2906:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2906:01GLOBECelldex Therapeutics Announces Proposed Public Offering of..
2024/2/2622:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2621:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2621:01EDGAR2Form 8-K - Current report
2024/2/2621:01GLOBECelldex Reports Fourth Quarter and Year End 2023 Financial..
2024/2/2504:05GLOBECelldex Therapeutics Presents Positive 12 Week Results from..
2024/2/1606:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1502:52EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1501:48EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1421:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1323:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0900:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0706:01GLOBECelldex to Participate in the Guggenheim Healthcare Talks..
2024/2/0522:01GLOBECelldex Announces Upcoming Presentation of Barzolvolimab..
2024/1/0506:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2806:15GLOBECelldex Therapeutics to Present at 6th Annual Evercore ISI..
2023/11/2106:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/11/0907:03EDGAR2Form 8-K - Current report
2023/11/0907:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/0813:15GLOBECelldex Therapeutics Announces Pricing of Public Offering of..
2023/11/0806:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/0806:01GLOBECelldex Therapeutics Announces Proposed Public Offering of..
2023/11/0623:00EDGAR2Form 8-K - Current report
2023/11/0620:30GLOBECelldex Therapeutics Announces Positive Topline Results from..
2023/11/0605:00GLOBECelldex Therapeutics Presents Positive Data from Prurigo..
2023/11/0405:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/11/0305:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0305:01EDGAR2Form 8-K - Current report
2023/11/0305:01GLOBECelldex Reports Third Quarter 2023 Financial Results and..
2023/9/2620:01GLOBECelldex Announces Acceptance of Abstract for Barzolvolimab..
2023/9/2521:31GLOBECelldex Therapeutics to Present at Cantor Global Healthcare..
2023/8/0905:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:01EDGAR2Form 8-K - Current report
2023/8/0905:01GLOBECelldex Reports Second Quarter 2023 Financial Results and..
2023/7/1121:01GLOBECelldex Announces Completion of Enrollment in Phase 2 Study..
2023/7/0621:01GLOBECelldex Announces First Patient Dosed in Phase 2 Study of..
2023/6/1023:45GLOBECelldex Therapeutics Presents Positive Data from..
2023/6/0905:01GLOBECelldex Therapeutics Announces Upcoming Barzolvolimab..
2023/6/0221:01GLOBECelldex Therapeutics to Present at Jefferies Healthcare..
2023/5/3121:01GLOBECelldex Announces First Patient Dosed in Phase 1 Study of..
2023/5/1521:01GLOBECelldex Therapeutics Presents Positive Preclinical Data from..

最近閲覧した銘柄

NASDAQ
CLDX
Celldex Therapeutics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有